文献速递新生儿

基于巩膜的智能手机应用在加纳筛查新生儿黄疸的验证

Validating a Sclera-Based Smartphone Application for Screening Jaundiced Newborns in Ghana.
PubMed 文献 · Pediatrics · 2022-01-01

该横断面研究在加纳纳入724名0-28天住院非危重婴儿,优化并验证基于巩膜的智能手机应用neoSCB筛查新生儿黄疸。在336名未治疗婴儿中,neoSCB单次图像识别TSB>14.62 mg/dL的敏感度0.94、特异度0.73、AUC 0.90,与JM-105经皮胆红素仪相当。

要点

  • neoSCB筛查TSB>14.62 mg/dL的敏感度0.94、特异度0.73,与JM-105相当。
  • SCB/TSB相关系数r=0.78,低于TcB/TSB的r=0.93。
  • 两设备在既往光疗婴儿中性能均降低。

核心结论

  • neoSCB诊断性能与JM-105相当,是潜在的可负担、非接触式新生儿黄疸筛查工具。

研究设计与样本

  • 横断面设计,2019年3月至2020年4月在加纳连续纳入0-28天住院非危重婴儿。
  • 共724名婴儿参与优化和验证阶段,验证分析纳入336名未治疗黄疸婴儿。
  • 使用neoSCB(Samsung Galaxy S8)量化SCB,JM-105(Dräger)测TcB,与床旁TSB比较。

主要发现

  • neoSCB单次图像识别TSB>14.62 mg/dL(250 μmol/L)的敏感度0.94(95%CI 0.91-0.97),特异度0.73(95%CI 0.68-0.78),AUC 0.90。
  • JM-105敏感度0.96(95%CI 0.90-0.99),特异度0.81(95%CI 0.76-0.86)。
  • TcB/TSB相关系数r=0.93(P<.01),SCB/TSB r=0.78(P<.01)。
  • 既往光疗婴儿(n=231)中两设备性能均降低。

关键数值与推荐

  • 筛查阳性阈值:TSB>14.62 mg/dL(250 μmol/L)。
  • neoSCB单次图像捕获用于识别该阈值以上的婴儿。

临床怎么用

  • 在资源有限地区可考虑neoSCB作为非接触式黄疸筛查工具,性能与JM-105相当。
  • 对既往接受光疗的婴儿,两种设备性能均降低,需谨慎解读结果。

局限性

  • 研究在加纳单国进行,外推性需进一步验证。
  • 既往光疗婴儿中设备性能降低,可能影响临床应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Reducing the burden of bilirubin-induced neurologic complications in low-resource countries requires reliable and accessible screening tools. We sought to optimize and validate a sclera-based smartphone application, Neonatal Scleral-Conjunctival Bilirubin (neoSCB), for screening neonatal jaundice. METHODS: Using a cross-sectional design, consecutive eligible infants (aged 0-28 days, in the hospital, not critically ill) were enrolled in Ghana from March 2019 to April 2020. Jaundice screening was performed with neoSCB (Samsung Galaxy S8) to quantify SCB and JM-105 (Dräger) for transcutaneous bilirubin (TcB). Screening values were compared with total serum bilirubin (TSB) measured at the point of care. RESULTS: Overall, 724 infants participated in the optimization and validation phases of the study. The analysis for validation included 336 infants with no previous treatment of jaundice. Single neoSCB image captures identified infants with TSB >14.62 mg/dL (250 μmol/L) with reasonably high sensitivity, specificity, and receiver operating characteristic area under the curve at 0.94 (95% confidence interval [CI], 0.91 to 0.97), 0.73 (95% CI, 0.68 to 0.78), and 0.90, respectively. These findings were comparable to the sensitivity and specificity of JM-105 (0.96 [95% CI, 0.90 to 0.99] and 0.81 [95% CI, 0.76 to 0.86], respectively). The TcB/TSB had a larger correlation coefficient (r = 0.93; P < .01) than SCB/TSB (r = 0.78; P < .01). Performance of both devices was lower in infants with previous phototherapy (n = 231). CONCLUSIONS: The diagnostic performance of neoSCB was comparable to JM-105 and is a potential, affordable, contact-free screening tool for neonatal jaundice.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Enweronu-Laryea C, Leung T, Outlaw F, et al. Validating a Sclera-Based Smartphone Application for Screening Jaundiced Newborns in Ghana. Pediatrics. 2022. PMID: 35656782. doi:10.1542/peds.2021-053600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。